STOCKS TELEGRAPH

Tag: SNES STOCK PRICE

  • SenesTech (SNES) Stock Jumps In Pre-Market After Positive Financials

    SenesTech (SNES) Stock Jumps In Pre-Market After Positive Financials

    Shares of SenesTech, Inc. (NASDAQ: SNES) experienced a sharp increase in value on the stock charts following the disclosure of its financial results. As of the last check, the SNES shares were trading at $2.59, a 13.60% gain in pre-market trading.

    Revenue Growth and Financial Performance

    SenesTech’s Q4 2024 revenue jumped from $295,000 to $501,000, a significant 70% rise over the same quarter the previous year. The impressive 206% rise in e-commerce sales was a major factor in this surge.

    Additionally, the firm improved its net loss, which went from $1.7 million in Q4 2023 to $1.3 million. This development is a product of SNES’s continual efforts to strengthen operational performance and polish its business strategy.

    Expanding the Evolve Product Line

    One of SenesTech’s most noteworthy achievements in 2024 was the success of its Evolve product line. The Evolve Rat, a rodent reproductive control device, has rapidly become the company’s best-selling product, generating 52% of Q4 2024 revenue.

    Evolve Mouse, which SNES also introduced in May 2024, immediately produced 24% of Q4 revenue. These devices, which were developed by a number of online merchants such as Amazon, Walmart, and Tractor Supply, were made to proactively manage rodent populations.

    International Growth and Strategic Alliances

    With distribution agreements struck in 10 nations and territories, SenesTech’s worldwide presence is only getting stronger. Shipments to Hong Kong, the United Arab Emirates, the Netherlands, and the Maldives are noteworthy, while distribution activities in Australia, New Zealand, and India are almost finished.

    SenesTech also obtained a sizable order for their Evolve Rat product, which will be used in the rat contraceptive trial program in New York City starting in April. SNES is concentrating on increasing operational effectiveness and cutting expenses with these developments.

    With the anticipated $2 million in incremental yearly savings from new projects, SNES will be one step closer to reaching cash flow breakeven at a lower revenue barrier of $7 million, rather than the previously projected $12 million. SenesTech is positioned for long-term, sustainable development and profitability thanks to these actions.

  • Here is why SenesTech Inc. (SNES) stock is skyrocketing in Friday’s Pre-market

    Here is why SenesTech Inc. (SNES) stock is skyrocketing in Friday’s Pre-market

    SenesTech Inc. (SNES) stock is soaring in Friday’s 19th March Pre-market session. As of this writing, it has gained 61.31%. Let’s try to findout what’s the reason behind pre-market surge.

    Successful completion of a long-term agricultural deployment of ContraPest

    Yesterday, after market close, SNES announced the successful results of ContraPestagricultural deployments. It showed success in reducing rat populations and improving operating economies in poultry settings.

    ContraPest is the company’s first fertility control product,for managing animal pest populations.

    ContraPest was used at an egg production farm on the west coast, where cameras were used to monitor the rat populations over a year. A reduction in rat activity was noted throughout ContraPest treatment. Over the year there was a 90% decline in rat activity.

    On a second pullet farm on the east coast, economic impacts and consumption rates caused by rats were recorded before and after the introduction of ContraPest.88% improvement in pullet survival after reducing their rat population with ContraPest.

    The CEO of SenesTechKen Siegel said that the results are immediately applicable to many other agricultural situations and ContraPest is now proven in the field to reduce infestations.

    Scheduling the release of Financial results

    On March 17, SNES said that SNES will report financial results for its fourth quarter and fiscal year 2020, ended December 31, 2020, after the market close on Thursday, March 25, 2021. SNES Stock has scheduled a conference call that same day, Thursday, March 25, 2021, at 5:00 pm ET, to review the results.

    About SNES

    SenesTech is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction. Senes Tech was founded by two scientists in 2003with a deep love for animals. SNES’s flagship product ContraPest is setting the new way for pest management, yielding proven and impressive results. ContraPest that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. SNES received EPA registration in 2016 and are currently registered in all 50 states and Washington D.C.

    Conclusion: The great results of ContraPest and the upcoming announcement of financial results is the main reason behind their pre-market rally. The positive trend for SNES stock can remain steady on the last day of the week.